We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Impax to Sell Generic Renvela, Renagel in 2014 After Genzyme Settlement
Impax to Sell Generic Renvela, Renagel in 2014 After Genzyme Settlement
September 7, 2012
Impax Laboratories can market generic versions of Genzyme’s kidney disease drugs Renvela and Renagel in 2014 under a settlement with the brand drugmaker.